Young Li
Stock Analyst at Jefferies
(0.50)
# 4,162
Out of 5,172 analysts
8
Total ratings
40%
Success rate
-17.64%
Average return
Main Sectors:
Stocks Rated by Young Li
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| STAA STAAR Surgical Company | Maintains: Buy | $28 → $22 | $17.52 | +22.72% | 1 | Jan 28, 2026 | |
| TMDX TransMedics Group | Initiates: Buy | $145 | $113.90 | +27.30% | 1 | Oct 13, 2025 | |
| RXST RxSight | Downgrades: Hold | $24 → $9 | $6.44 | +39.75% | 2 | Jul 10, 2025 | |
| COO The Cooper Companies | Upgrades: Buy | $107 → $115 | $69.96 | +64.38% | 1 | Jul 16, 2024 | |
| HYPR Hyperfine | Initiates: Hold | $1.25 | $1.24 | +0.81% | 1 | Nov 30, 2023 | |
| ENOV Enovis | Initiates: Buy | $60 | $21.85 | +174.60% | 1 | Oct 12, 2022 | |
| ANIK Anika Therapeutics | Initiates: Neutral | $46 | $13.85 | +232.13% | 1 | Jul 16, 2021 |
STAAR Surgical Company
Jan 28, 2026
Maintains: Buy
Price Target: $28 → $22
Current: $17.52
Upside: +22.72%
TransMedics Group
Oct 13, 2025
Initiates: Buy
Price Target: $145
Current: $113.90
Upside: +27.30%
RxSight
Jul 10, 2025
Downgrades: Hold
Price Target: $24 → $9
Current: $6.44
Upside: +39.75%
The Cooper Companies
Jul 16, 2024
Upgrades: Buy
Price Target: $107 → $115
Current: $69.96
Upside: +64.38%
Hyperfine
Nov 30, 2023
Initiates: Hold
Price Target: $1.25
Current: $1.24
Upside: +0.81%
Enovis
Oct 12, 2022
Initiates: Buy
Price Target: $60
Current: $21.85
Upside: +174.60%
Anika Therapeutics
Jul 16, 2021
Initiates: Neutral
Price Target: $46
Current: $13.85
Upside: +232.13%